Royal Bank of Canada
ELOX

Royal Bank of Canada’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Royal Bank of Canada’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-526
Closed -$3K – 7914
2023
Q3 		$3K Sell
526
-260
-33% -$1.46K ﹤0.01% 6756
2023
Q2 		$3K Buy
786
+743
+1,728% +$4.76K ﹤0.01% 6826
2023
Q1 		$0 Buy
43
+29
+207% +$105 ﹤0.01% 7859
2022
Q4 		$0 Buy
+14
New +$68 ﹤0.01% 8128
2021
Q3 		– Sell
-301
Closed -$24K – 8057
2021
Q2 		$24K Buy
301
+249
+479% +$20.8K ﹤0.01% 6485
2021
Q1 		$7K Buy
52
+19
+58% +$2.9K ﹤0.01% 6971
2020
Q4 		$5K Buy
33
+15
+83% +$1.83K ﹤0.01% 6687
2020
Q3 		$2K Sell
18
-1
-5% -$120 ﹤0.01% 6358
2020
Q2 		$2K Sell
19
-1
-5% -$113 ﹤0.01% 6342
2020
Q1 		$1K Sell
20
-39
-66% -$6.35K ﹤0.01% 6551
2019
Q4 		$17K Buy
59
+40
+211% +$8.06K ﹤0.01% 5934
2019
Q3 		$3K Sell
19
-4
-17% -$1.14K ﹤0.01% 6237
2019
Q2 		$9K Buy
23
+5
+28% +$2.1K ﹤0.01% 6075
2019
Q1 		$8K Sell
18
-5
-22% -$2.43K ﹤0.01% 6111
2018
Q4 		$10K Sell
23
-6
-21% -$3.31K ﹤0.01% 5909
2018
Q3 		$20K Buy
29
+10
+53% +$6.4K ﹤0.01% 5690
2018
Q2 		$13K Buy
+19
New +$12.3K ﹤0.01% 5745

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Royal Bank of Canada's ELOX Position: Q4 2023 in Review

Royal Bank of Canada sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 526 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in ELOX in Q2 2018 and held it in 17 quarters. The position peaked at $24K in Q2 2021. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • Royal Bank of Canada reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 526 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $3K.
  • Royal Bank of Canada first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
  • Royal Bank of Canada's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $24K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.